Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Medicinal Chemistry|September 19, 2013
Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding groupLucie Maingot, Jamal Elbakali, Julie Dumont, et al.European Journal of Medicinal Chemistry|July 6, 2019
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screeningFlorence Leroux, Damien Bosc, Terence Beghyn, et al.European Journal of Medicinal Chemistry|November 24, 2021
Identification of indole-based activators of insulin degrading enzymeNicolas Kraupner, Chau Phi Dinh, Xiaoan Wen, et al.European Journal of Medicinal Chemistry|March 21, 2026
Discovery of pyrimidine-based small activators of insulin degrading enzymeJamal El Bakali, Cyril Ronco, Valérie Landry, et al.Journal of Medicinal Chemistry|October 7, 2017
Controlling Plasma Stability of Hydroxamic Acids: A MedChem ToolboxPaul Hermant, Damien Bosc, Catherine Piveteau, et al.European Journal of Medicinal Chemistry|December 10, 2014
Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzymeJulie Charton, Marion Gauriot, Jane Totobenazara, et al.Angewandte Chemie (International Ed. in English)|July 29, 2022
Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target-Guided SynthesisVirgyl Camberlein, Charlotte Fléau, Pierre Sierocki, et al.Nature Communications|September 24, 2015
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in miceRebecca Deprez-Poulain, Nathalie Hennuyer, Damien Bosc, et al.British Journal of Pharmacology|March 19, 2026
Enhancing antitumour response to proteasome inhibitors with inhibitors of insulin-degrading enzyme, a new molecular vulnerability in multiple myelomaLaetitia Lesire, Rebecca Deprez-Poulain, Damien Bosc, et al.Pageof 2